| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 5.01e-07 | 4 | 101 | 3 | GO:0047655 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 4.39e-05 | 14 | 101 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 4.39e-05 | 14 | 101 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 5.47e-05 | 15 | 101 | 3 | GO:0052650 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.51e-04 | 4 | 101 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 3.36e-04 | 27 | 101 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 3.75e-04 | 6 | 101 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 5.60e-04 | 32 | 101 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | NADP+ binding | 8.91e-04 | 9 | 101 | 2 | GO:0070401 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.59e-05 | 10 | 97 | 3 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.59e-05 | 10 | 97 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.59e-05 | 10 | 97 | 3 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 1.59e-05 | 10 | 97 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.59e-05 | 10 | 97 | 3 | IPR020471 | |
| Domain | PLC-gamma | 2.67e-05 | 2 | 97 | 2 | IPR016279 | |
| Domain | - | 7.24e-05 | 16 | 97 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 8.76e-05 | 17 | 97 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 8.76e-05 | 17 | 97 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 8.76e-05 | 17 | 97 | 3 | IPR001395 | |
| Domain | PH | 1.92e-04 | 229 | 97 | 7 | PF00169 | |
| Domain | SMC | 2.64e-04 | 5 | 97 | 2 | IPR024704 | |
| Domain | SMC_hinge | 3.95e-04 | 6 | 97 | 2 | SM00968 | |
| Domain | SMC_hinge | 3.95e-04 | 6 | 97 | 2 | PF06470 | |
| Domain | SMC_hinge | 3.95e-04 | 6 | 97 | 2 | IPR010935 | |
| Domain | PH | 6.16e-04 | 278 | 97 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 6.29e-04 | 279 | 97 | 7 | PS50003 | |
| Domain | PH_domain | 6.43e-04 | 280 | 97 | 7 | IPR001849 | |
| Domain | S15_NS1_RNA-bd | 7.32e-04 | 8 | 97 | 2 | IPR009068 | |
| Domain | RecF/RecN/SMC_N | 7.32e-04 | 8 | 97 | 2 | IPR003395 | |
| Domain | SMC_N | 7.32e-04 | 8 | 97 | 2 | PF02463 | |
| Domain | SH2 | 1.90e-03 | 101 | 97 | 4 | PF00017 | |
| Domain | SH2 | 2.59e-03 | 110 | 97 | 4 | SM00252 | |
| Domain | SH2 | 2.68e-03 | 111 | 97 | 4 | PS50001 | |
| Domain | EF-hand_like | 2.68e-03 | 15 | 97 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 2.68e-03 | 15 | 97 | 2 | PF00387 | |
| Domain | PLCYc | 2.68e-03 | 15 | 97 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.68e-03 | 15 | 97 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 2.68e-03 | 15 | 97 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 2.68e-03 | 15 | 97 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.68e-03 | 15 | 97 | 2 | IPR015359 | |
| Domain | SH2 | 2.77e-03 | 112 | 97 | 4 | IPR000980 | |
| Domain | - | 2.77e-03 | 112 | 97 | 4 | 3.30.505.10 | |
| Domain | MMR_HSR1 | 3.45e-03 | 17 | 97 | 2 | PF01926 | |
| Domain | PI-PLC-X | 3.87e-03 | 18 | 97 | 2 | PF00388 | |
| Domain | PLCXc | 3.87e-03 | 18 | 97 | 2 | SM00148 | |
| Domain | RhoGAP | 4.11e-03 | 62 | 97 | 3 | SM00324 | |
| Domain | - | 4.27e-03 | 391 | 97 | 7 | 2.30.29.30 | |
| Domain | RhoGAP | 4.30e-03 | 63 | 97 | 3 | PF00620 | |
| Domain | GTP_binding_domain | 4.31e-03 | 19 | 97 | 2 | IPR006073 | |
| Domain | PIPLC_X_DOMAIN | 4.31e-03 | 19 | 97 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.31e-03 | 19 | 97 | 2 | IPR000909 | |
| Domain | RhoGAP_dom | 4.50e-03 | 64 | 97 | 3 | IPR000198 | |
| Domain | RHOGAP | 4.50e-03 | 64 | 97 | 3 | PS50238 | |
| Domain | - | 4.50e-03 | 64 | 97 | 3 | 1.10.555.10 | |
| Pathway | PID_EPO_PATHWAY | 2.69e-05 | 33 | 75 | 4 | M233 | |
| Pubmed | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. | 2.60e-08 | 3 | 104 | 3 | 17381426 | |
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 27221712 | ||
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 10092857 | ||
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 15184383 | ||
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 29776906 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 COMT MARS1 SMC1A RPS13 PHB2 EEF1B2 CS ARAP3 RBM19 PDCD11 PLCG1 PLCG2 PARD3 DHX29 UTRN PCK2 | 5.43e-07 | 1353 | 104 | 17 | 29467282 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TES DRG2 DMAC2 PHB2 MAP3K4 EEF1B2 EHMT2 PDCD11 SMARCD2 PLCG1 DHX29 PCK2 | 1.36e-06 | 704 | 104 | 12 | 29955894 |
| Pubmed | Fine specificity and molecular competition in SLAM family receptor signalling. | 3.07e-06 | 10 | 104 | 3 | 24642916 | |
| Pubmed | CYLD ARHGAP10 SLC26A2 NOA1 GRIK1 METTL6 SEMA3D NEK5 MANSC4 DHX29 HYDIN | 6.88e-06 | 686 | 104 | 11 | 29987050 | |
| Pubmed | Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. | 8.86e-06 | 2 | 104 | 2 | 34954342 | |
| Pubmed | SMC1α Substitutes for Many Meiotic Functions of SMC1β but Cannot Protect Telomeres from Damage. | 8.86e-06 | 2 | 104 | 2 | 29337080 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15745835 | ||
| Pubmed | Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. | 8.86e-06 | 2 | 104 | 2 | 25120755 | |
| Pubmed | Phospholipase C gamma 2 is essential for specific functions of Fc epsilon R and Fc gamma R. | 8.86e-06 | 2 | 104 | 2 | 12471105 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21087085 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8526877 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24100137 | ||
| Pubmed | Molecular species of phospholipids in a murine stem-cell line responsive to erythropoietin. | 8.86e-06 | 2 | 104 | 2 | 8615781 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 36518763 | ||
| Pubmed | Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. | 8.86e-06 | 2 | 104 | 2 | 28929377 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7578036 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8541228 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 32628753 | ||
| Pubmed | Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. | 8.86e-06 | 2 | 104 | 2 | 33644071 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12732097 | ||
| Pubmed | Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks. | 8.86e-06 | 2 | 104 | 2 | 33945128 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25793864 | ||
| Pubmed | Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry. | 8.86e-06 | 2 | 104 | 2 | 28003428 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23146748 | ||
| Pubmed | Identification and characterization of a novel human aldose reductase-like gene. | 8.86e-06 | 2 | 104 | 2 | 9565553 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25538260 | ||
| Pubmed | Functional expression of novel human and murine AKR1B genes. | 8.86e-06 | 2 | 104 | 2 | 21276782 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 31911858 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21329684 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15972651 | ||
| Pubmed | Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism. | 8.86e-06 | 2 | 104 | 2 | 29617059 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | STARD13 COMT LONP2 ARHGAP10 SMC1A RPS13 PHB2 USP8 CS NEK5 CEP44 TRAPPC10 PARD3 CTSV PCK2 | 9.15e-06 | 1321 | 104 | 15 | 27173435 |
| Pubmed | 2.46e-05 | 114 | 104 | 5 | 28245920 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 15214048 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11564881 | ||
| Pubmed | FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth. | 2.65e-05 | 3 | 104 | 2 | 37527040 | |
| Pubmed | Phospholipase Cγ2 plays a role in TCR signal transduction and T cell selection. | 2.65e-05 | 3 | 104 | 2 | 22837484 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17015722 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11331309 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 7510692 | ||
| Pubmed | PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development. | 2.65e-05 | 3 | 104 | 2 | 29133930 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 28786489 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 20872577 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11507676 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9592050 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 10770799 | ||
| Pubmed | The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth. | 2.65e-05 | 3 | 104 | 2 | 36720499 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 7774933 | ||
| Pubmed | An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion. | 5.29e-05 | 4 | 104 | 2 | 15372077 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 20070863 | ||
| Pubmed | ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca(2+) signaling cascade. | 5.29e-05 | 4 | 104 | 2 | 21875593 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 11414741 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 9398617 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 15817477 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 8627166 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 18378693 | ||
| Pubmed | Interferon-induced guanylate-binding proteins: mapping of the murine Gbp-1 locus to chromosome 3. | 5.29e-05 | 4 | 104 | 2 | 3927587 | |
| Pubmed | Distinct Roles of Meiosis-Specific Cohesin Complexes in Mammalian Spermatogenesis. | 5.29e-05 | 4 | 104 | 2 | 27792785 | |
| Pubmed | Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. | 5.29e-05 | 4 | 104 | 2 | 11744703 | |
| Pubmed | Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry. | 5.29e-05 | 4 | 104 | 2 | 17023658 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 21179467 | ||
| Pubmed | 6.16e-05 | 329 | 104 | 7 | 35562734 | ||
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | DRG2 COMT MARS1 NOA1 DMAC2 PHB2 OTC CS TAMM41 AKR1B10 DHX29 PCK2 | 7.07e-05 | 1047 | 104 | 12 | 18614015 |
| Pubmed | 8.63e-05 | 77 | 104 | 4 | 22973453 | ||
| Pubmed | LAB: a new membrane-associated adaptor molecule in B cell activation. | 8.80e-05 | 5 | 104 | 2 | 12514734 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 29897336 | ||
| Pubmed | iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE. | 8.80e-05 | 5 | 104 | 2 | 29897333 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 9819383 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 10350061 | ||
| Pubmed | Identification and molecular characterization of the mammalian α-kleisin RAD21L. | 8.80e-05 | 5 | 104 | 2 | 21527826 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 12955498 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 20719962 | ||
| Pubmed | DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. | 8.80e-05 | 5 | 104 | 2 | 21682944 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 18219272 | ||
| Pubmed | Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. | 8.80e-05 | 5 | 104 | 2 | 19056831 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 12759374 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 26291391 | ||
| Pubmed | PITPNM2 MARS1 RPS13 PHB2 EEF1B2 CS RNPEP AKR1B10 OSBPL8 TRAPPC10 CROCC AKR1B1 DHX29 UTRN | 9.34e-05 | 1431 | 104 | 14 | 37142655 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | DRG2 COMT MARS1 NOA1 DMAC2 PHB2 CS TAMM41 AKR1B15 DHX29 PCK2 | 1.05e-04 | 926 | 104 | 11 | 20877624 |
| Pubmed | 1.20e-04 | 159 | 104 | 5 | 30581152 | ||
| Pubmed | CYLD TES DCDC1 ARHGAP10 KAT6A PEX1 NSRP1 RESF1 TAF9B EHMT2 SMARCD2 PARD3 | 1.29e-04 | 1116 | 104 | 12 | 31753913 | |
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 8739298 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 1.32e-04 | 6 | 104 | 2 | 21762810 | |
| Pubmed | Cep44 functions in centrosome cohesion by stabilizing rootletin. | 1.32e-04 | 6 | 104 | 2 | 31974111 | |
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 14978237 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 8892607 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PITPNM2 ARHGAP10 MARS1 KAT6A DMAC2 ANKMY1 GRIK1 NSRP1 GALNT11 PLCG1 PARD3 CROCC UTRN DOP1A | 1.42e-04 | 1489 | 104 | 14 | 28611215 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DRG2 MARS1 SMC1A RPS13 PHB2 EEF1B2 CS TAF9B TAMM41 OSBPL8 PDCD11 SMARCD2 PCK2 | 1.56e-04 | 1318 | 104 | 13 | 30463901 |
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 1.84e-04 | 7 | 104 | 2 | 17937400 | |
| Pubmed | Comparison of the physical and recombination maps of the mouse X chromosome. | 1.84e-04 | 7 | 104 | 2 | 2571569 | |
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 12810672 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 33139725 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 27609517 | ||
| Pubmed | Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase Cgamma. | 1.84e-04 | 7 | 104 | 2 | 15953601 | |
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 17634444 | ||
| GeneFamily | Aldo-keto reductases | 2.05e-05 | 15 | 66 | 3 | 399 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 2.72e-04 | 7 | 66 | 2 | 761 | |
| GeneFamily | Cohesin complex | 3.62e-04 | 8 | 66 | 2 | 1060 | |
| GeneFamily | Phospholipases | 4.82e-04 | 42 | 66 | 3 | 467 | |
| GeneFamily | SH2 domain containing | 5.07e-04 | 101 | 66 | 4 | 741 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.16e-03 | 19 | 66 | 2 | 832 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.12e-07 | 136 | 104 | 6 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.12e-07 | 136 | 104 | 6 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.12e-07 | 136 | 104 | 6 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.12e-07 | 136 | 104 | 6 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.12e-07 | 136 | 104 | 6 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 173 | 104 | 6 | a7cc63bb3ab41feb9e4072700d44dbbbc62c47c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 173 | 104 | 6 | e3e3a67a5a93ef4475224a256d45ae24526383cc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 177 | 104 | 6 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 177 | 104 | 6 | ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 177 | 104 | 6 | bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 178 | 104 | 6 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 178 | 104 | 6 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-06 | 181 | 104 | 6 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 182 | 104 | 6 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 182 | 104 | 6 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.84e-06 | 185 | 104 | 6 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.99e-06 | 186 | 104 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 5.31e-06 | 188 | 104 | 6 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | ASK454-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.64e-06 | 190 | 104 | 6 | 5cea6480f08253d7adf484e511d3fdfa96641268 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.54e-06 | 195 | 104 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.54e-06 | 195 | 104 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 6.74e-06 | 196 | 104 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.56e-06 | 200 | 104 | 6 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.56e-06 | 200 | 104 | 6 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.56e-06 | 200 | 104 | 6 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.56e-06 | 200 | 104 | 6 | 873def69bf55ccbfc944bc10c5afc06be019c312 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.56e-06 | 200 | 104 | 6 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.39e-05 | 146 | 104 | 5 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | Hippocampus-Macroglia-CSF_related|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.89e-05 | 152 | 104 | 5 | c2b6cc41546cbd46b9ea5d28a7c66f6330a27df2 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.16e-05 | 164 | 104 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.30e-05 | 83 | 104 | 4 | 1ab68323518adc7fd0a459b41fad12d60f97eb5c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.30e-05 | 83 | 104 | 4 | 75b27d91a4473286f4b40027e96ac5246f5abe5b | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 167 | 104 | 5 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 167 | 104 | 5 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 167 | 104 | 5 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 167 | 104 | 5 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 4.54e-05 | 167 | 104 | 5 | edb722ee9b6ccd00fb038f702be8664020932659 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 170 | 104 | 5 | 79420950d5e4b5da9f52d2a8a8ce096ae44a5edf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.08e-05 | 171 | 104 | 5 | e1fe07652c10c37191d1471ddaea500f74269e0c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-05 | 173 | 104 | 5 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-05 | 173 | 104 | 5 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-05 | 176 | 104 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.82e-05 | 176 | 104 | 5 | d09e28606e2a6ed1f660898316765ca215085c18 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.98e-05 | 177 | 104 | 5 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 178 | 104 | 5 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 178 | 104 | 5 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-05 | 178 | 104 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-05 | 179 | 104 | 5 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 179 | 104 | 5 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.47e-05 | 180 | 104 | 5 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.82e-05 | 182 | 104 | 5 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.82e-05 | 182 | 104 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.82e-05 | 182 | 104 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.82e-05 | 182 | 104 | 5 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-05 | 183 | 104 | 5 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.00e-05 | 183 | 104 | 5 | 58847e8f3a7ce3e33adba9477bcd55e769a64a90 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.00e-05 | 183 | 104 | 5 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-05 | 183 | 104 | 5 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.00e-05 | 183 | 104 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 184 | 104 | 5 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.18e-05 | 184 | 104 | 5 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 184 | 104 | 5 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 184 | 104 | 5 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.18e-05 | 184 | 104 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.37e-05 | 185 | 104 | 5 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.37e-05 | 185 | 104 | 5 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.37e-05 | 185 | 104 | 5 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 7.37e-05 | 185 | 104 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 7.56e-05 | 186 | 104 | 5 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.56e-05 | 186 | 104 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-05 | 187 | 104 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 7.75e-05 | 187 | 104 | 5 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.75e-05 | 187 | 104 | 5 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 7.75e-05 | 187 | 104 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.75e-05 | 187 | 104 | 5 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-05 | 187 | 104 | 5 | 88f785932e67c613db0dda84496de351359ed962 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-05 | 187 | 104 | 5 | 8896a00b30d11b90ca42726d4e122174a30b161b | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.75e-05 | 187 | 104 | 5 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 7.95e-05 | 188 | 104 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.95e-05 | 188 | 104 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.95e-05 | 188 | 104 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.95e-05 | 188 | 104 | 5 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.15e-05 | 189 | 104 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.15e-05 | 189 | 104 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.15e-05 | 189 | 104 | 5 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 8.15e-05 | 189 | 104 | 5 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 8.15e-05 | 189 | 104 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 8.15e-05 | 189 | 104 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.15e-05 | 189 | 104 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 8.15e-05 | 189 | 104 | 5 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.35e-05 | 190 | 104 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.35e-05 | 190 | 104 | 5 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.35e-05 | 190 | 104 | 5 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.35e-05 | 190 | 104 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 8.35e-05 | 190 | 104 | 5 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.35e-05 | 190 | 104 | 5 | 088e3f39a1e5e11354d6e7458e8e6a39f14936b3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.35e-05 | 190 | 104 | 5 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.35e-05 | 190 | 104 | 5 | 35248a8be476ea8d06d67c3d98a25be1f7c150b7 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.35e-05 | 190 | 104 | 5 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | Severe-Lymphoid-NK-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 8.35e-05 | 190 | 104 | 5 | e67803bf55a3f8e47a69ff1829c9100f870d7527 | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A | 1.56e-08 | 192 | 102 | 10 | 6162_DN | |
| Drug | lindane | 6.09e-06 | 154 | 102 | 7 | CID000000727 | |
| Drug | Glyceraldehyde | 1.02e-05 | 10 | 102 | 3 | ctd:D005985 | |
| Drug | 4-oxoretinaldehyde | 1.99e-05 | 2 | 102 | 2 | ctd:C099660 | |
| Drug | propioin | 1.99e-05 | 2 | 102 | 2 | ctd:C523189 | |
| Drug | dehydroretinal | 1.99e-05 | 2 | 102 | 2 | ctd:C017184 | |
| Drug | Pentanones | 1.99e-05 | 2 | 102 | 2 | ctd:D010422 | |
| Drug | 4-hydroxyretinal | 1.99e-05 | 2 | 102 | 2 | ctd:C057180 | |
| Drug | 6-demethoxycapillarisin | 1.99e-05 | 2 | 102 | 2 | CID005316511 | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 7526_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; PC3; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 5879_DN | |
| Drug | citric acid | 3.29e-05 | 357 | 102 | 9 | CID000000311 | |
| Drug | 3-aminophenylboronic acid | 4.04e-05 | 85 | 102 | 5 | CID000092269 | |
| Disease | aldose reductase measurement | 6.79e-05 | 4 | 100 | 2 | EFO_0801364 | |
| Disease | tyrosine-protein kinase TEC measurement | 6.79e-05 | 4 | 100 | 2 | EFO_0020830 | |
| Disease | testosterone measurement | STARD13 DRG2 DCDC1 ARHGAP10 MARS1 SEMA3D RGS6 DGKK AKR1B15 PLCG1 AKR1B1 UTRN LRRC36 | 3.73e-04 | 1275 | 100 | 13 | EFO_0004908 |
| Disease | symmetrical dimethylarginine measurement | 4.03e-04 | 9 | 100 | 2 | EFO_0006523 | |
| Disease | white matter growth measurement | 4.03e-04 | 9 | 100 | 2 | EFO_0009335 | |
| Disease | juvenile rheumatoid arthritis (is_implicated_in) | 8.66e-04 | 13 | 100 | 2 | DOID:676 (is_implicated_in) | |
| Disease | ulcerative colitis | 9.98e-04 | 335 | 100 | 6 | EFO_0000729 | |
| Disease | Endometrial Neoplasms | 1.02e-03 | 58 | 100 | 3 | C0014170 | |
| Disease | ceramide measurement | 1.25e-03 | 235 | 100 | 5 | EFO_0010222 | |
| Disease | Myeloid Leukemia | 1.68e-03 | 18 | 100 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.68e-03 | 18 | 100 | 2 | C0023466 | |
| Disease | cystathionine measurement | 1.87e-03 | 19 | 100 | 2 | EFO_0010474 | |
| Disease | Endometrial Carcinoma | 1.90e-03 | 72 | 100 | 3 | C0476089 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLKKSYCQRQGVPVN | 46 | G2XKQ0 | |
| TKVVNPLKLYGAQIK | 91 | Q6ZTR7 | |
| LPQKNQRLEKYKDVI | 1006 | Q8WWN8 | |
| KKKPFVYTQGQAVLN | 161 | Q9H4A4 | |
| RKKGYVTPVKNQKQC | 121 | O60911 | |
| QKVLARYLKRLQPGT | 786 | P33076 | |
| RKKHIYIPKNGQINF | 366 | Q8NHS2 | |
| LNYKDKKLNIGPAIR | 96 | Q8N9W6 | |
| KAPSRYNIKIKIRQL | 191 | P39086 | |
| YNIKIKIRQLPSGNK | 196 | P39086 | |
| NYKPILTKKQFIQCG | 86 | Q9C0F1 | |
| LNKPGLKYKPVTNQV | 171 | O60218 | |
| NAKYQVVPKKLTIGK | 51 | Q5JWR5 | |
| PRQLYLSVKQGELQK | 651 | Q96KQ7 | |
| PEGNQKKKRTILQFL | 31 | Q9NW81 | |
| LQSTPKYQKLLKERQ | 556 | Q7Z478 | |
| IKKQIRQREKYGPNP | 281 | Q6P1M9 | |
| LNKPGLKYKPAVNQI | 171 | P15121 | |
| YNQLKQKGVKVPPLQ | 626 | Q2M243 | |
| YRKPEQAQKALKQLQ | 781 | Q9Y4C8 | |
| RQYGLILPKKTQQLH | 6 | Q9H0G5 | |
| NGKKTKRPRVIVDYN | 411 | Q96DM1 | |
| RRLKNPQKVKKSVYG | 221 | P49758 | |
| QIGLLNKDLKPQTYR | 496 | Q5JSJ4 | |
| VALQTKGALQKKPLY | 206 | Q9NPC2 | |
| LNPIIYGVKTKQIKD | 271 | P0C646 | |
| LNGKRGLIPQNYVKL | 771 | A1A4S6 | |
| KRIAVKPSNLYKQPN | 1651 | M0R2J8 | |
| IQRPGLIKIRYKNAA | 1016 | Q5KSL6 | |
| YLAVRQLKNNLKGPI | 356 | Q86WA8 | |
| VQLKPKHQPYKLGRQ | 86 | Q9BZ67 | |
| VQLKPKNQPYKLGRQ | 86 | Q9BZ68 | |
| YKPIKKIQLQGGITS | 281 | Q8N1V2 | |
| LLEQQGLIRKLPKYN | 76 | Q16822 | |
| INRQKSKYNLPLTKI | 211 | Q12796 | |
| PKANKRKNQNIGYKL | 256 | Q9UGI6 | |
| LLQQLNKEPKGYSGK | 691 | Q1X8D7 | |
| RIKQKGEYLPLLQGK | 66 | P00480 | |
| QYKLKVEKQLGLRPS | 416 | Q6P3R8 | |
| VQKYLPGKIKVIRNT | 206 | Q8NCW6 | |
| QFQLRGKPKAKYLVR | 406 | Q8TB73 | |
| QYKPGQRKSGSLQIK | 316 | A6NHS7 | |
| YQVPRKGIQAKEVLK | 446 | P32456 | |
| LNNGPQRIGRKYKKV | 431 | P00451 | |
| IIRQKPVDLLKYNQK | 966 | P16885 | |
| LNPLIYTLRNKKVKG | 286 | Q8NGU4 | |
| QIYIVGRPTKKLQQQ | 1226 | Q9BZ72 | |
| IRKIQKVVNTYTPGK | 361 | Q8WWQ2 | |
| KKKLREYQQRNSPGV | 26 | Q08379 | |
| PGYIKLRKIRAAQNI | 246 | Q99623 | |
| GNQIIYKLQTKRKLP | 386 | Q6UWY5 | |
| VLQNIYKVLKPGKSV | 171 | Q8TCB7 | |
| LKPGVLLIYKTQKNG | 171 | Q9BZF1 | |
| QKKAAQIKRRYTNPI | 321 | Q92794 | |
| YTNPIGRPKNRLKKQ | 331 | Q92794 | |
| VGASQDIIPQLKKKY | 166 | P21964 | |
| QLVQRLQGKILQYKK | 171 | Q5TZA2 | |
| AKQPLQLKNRGKYEI | 3066 | Q4G0P3 | |
| FNKKLITGIIYPQNK | 306 | Q9Y6W3 | |
| LNKTYQNLKRKPVAV | 2141 | Q9UFH2 | |
| YKIVPNVLLEQGKAK | 381 | O75390 | |
| PLLVKIQKQTYKFRN | 216 | Q9P2S6 | |
| QRKGILKNRLQYPLV | 3006 | Q9NYQ7 | |
| QKLLKVPKGSIGQYI | 36 | Q9NQC7 | |
| KLVPVGYGIKKLQIQ | 176 | P24534 | |
| TYGKLVKLLSPKQQQ | 331 | O43933 | |
| PYIVNIKGQRIKKSV | 661 | Q8NC60 | |
| NKYPPINLKIKCNRL | 2171 | A6NMZ7 | |
| QSKNLYKIPLRNLVG | 846 | Q5VVW2 | |
| YNTKKIGKRLNIQLK | 451 | Q8TEW0 | |
| RYSQKLKKKIQVQQP | 436 | Q8N328 | |
| KSKQYVKVQIPGLEN | 846 | Q9Y6R4 | |
| NYRLKSLIKKGPNQG | 126 | Q9HBM6 | |
| TRYNKIKAIPIQQRK | 1841 | P46939 | |
| RVIQKKYATGKPDQK | 831 | Q9Y3M8 | |
| EGAQYRKKQLAKQLP | 141 | Q9UGI8 | |
| QQKKKTSPLNYKERL | 16 | P42680 | |
| PPQVKDQKKLYLNRV | 1571 | Q9HCM1 | |
| KPYITINNLKPRENK | 241 | Q9UQ74 | |
| ILKQKAPQQYRIRAK | 351 | Q9NUX5 | |
| LQIYRRLGKPKITQS | 126 | Q9UIB8 | |
| VGIRLNKHKPNIYFK | 166 | P55039 | |
| KQKYPEQQGRFAKLL | 476 | P28702 | |
| KPLTQKRKLRIYISN | 186 | Q92925 | |
| GTLKQNIPRLKLTYK | 36 | O95025 | |
| LNKPGLKYKPVTNQV | 171 | C9JRZ8 | |
| VILKGLARPQTNVYK | 201 | Q8NA66 | |
| KITIPKQQRYGKGII | 371 | Q53H76 | |
| PLLKAQEYIRQKNKG | 216 | Q14690 | |
| QKTKKQDIPRQLVYI | 186 | Q8N609 | |
| VSAYKNLQIKPGIKI | 566 | P50443 | |
| LNQKRPQYIKAKENT | 291 | Q8NDV3 | |
| KKAYRLGSQKPVQRA | 266 | Q96HA7 | |
| QIYKLAKKGLTPSQI | 36 | P62277 | |
| KGLKTGYRAVPLKNN | 1181 | P19174 | |
| LNQKRPQYIKAKENT | 291 | Q14683 | |
| KGTGPNRKLIYNFKQ | 66 | Q9H106 | |
| NNLYIAGRLQKPVKI | 126 | Q96BW9 | |
| KRQGVKKLLGQYIPL | 326 | Q9BQ16 | |
| QRPENKGKNRYKNIL | 266 | P29350 | |
| QLLNQPKITADKRYK | 201 | O60765 | |
| RKKAPQKAEIYLQGA | 491 | P48553 | |
| LKINPKRYKGNFLQS | 1286 | Q5JPB2 | |
| VPKIKGNRKYQRPTV | 16 | A6NGA9 | |
| DLSQYVIGPKNNLKK | 1036 | P40818 | |
| KQQGVLALRPYLQKQ | 191 | P56192 |